Jonathan James

How strong partnerships can drive early-phase clinical trials

Sitting Down with Michael Tanner, Research Fellow in the School of Engineering and Physical Sciences at Heriot Watt University, Edinburgh, UK.

Researchers fine-tune 3D printing technology to create better biomimetic corneas – and predict a “breakthrough” in global transplantation practice.

Could modulation of fibroblast growth factor 21 translate into a new treatment for non-alcoholic fatty liver disease?

Combining metabolomics and DNA sequencing could be the key to discovering new inborn errors of metabolism in children.

The application of CRISPR on a genome-wide scale provides a major insight into tumor dependency.

Artificial intelligence holds the key to improving embryo selection for in vitro fertilization.

Prostate cancer prognosis presents a challenge – but a new algorithmic tool may help personalize predictions

We explore the work of researchers aiming to revolutionize the diagnosis of fibromyalgia and cholera using blood-based technologies.

How sex-dependent differences in molecular mechanisms could underpin men and women’s distinct experiences of chronic neuropathic pain.